Navigation Links
Malaria Vaccine Shows Promise in Small Trial

First test in country where disease is endemic produced strong results

THURSDAY, Jan. 24 (HealthDay News) -- A new malaria vaccine looked strong in a small trial conducted in Mali by a team of international researchers.

The vaccine -- designed to prevent the malaria parasite from entering blood cells -- was safe and provoked strong immune responses (up to a sixfold increase in vaccine-specific antibodies) in the 40 adults who received it, according to the 17-member research team, based at the Malaria Research and Training Center at the University of Bamako.

The volunteers were given three injections of full or half doses of the vaccine, with one month between each injection. The injections began in late December 2004, at the end of the malaria season in the rural town of Bandiagara in northeast Mali.

The study was published in the current issue of PLoS ONE.

This trial -- the first test of the vaccine in a malaria-endemic country -- was supported by the U.S. National Institute of Allergy and Infectious Diseases, which also helps fund the Malaria Research and Training Center. The team is now conducting a trial of the vaccine in 400 Malian children, aged 1 to 6.

Malaria is a leading cause of death in Africa and other developing countries. It kills more than 1 million people a year, most of them children.

More information

The U.S. Centers for Disease Control and Prevention has more about malaria.

-- Robert Preidt

SOURCE: U.S. National Institute of Allergy and Infectious Diseases, news release, Jan. 22, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Research discovers new compounds active against tuberculosis and malaria
2. Malaria Drug Promising Against Cancer
3. You can teach an old dog new tricks: anti-malarial prevents cancer in mice
4. McGill researchers report breakthrough in rapid malaria detection
5. Malcolm X Daughter Travels to Ancestral Home; Joins Muslim-American Leadership to Fight Malaria in Mali
6. Malaria Community Applauds Clintons $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments
7. Study of malaria parasites reveals new parasitic states
8. Holiday Cards That Save Lives Available for Purchase From Malaria No More
9. Immtech Completes Malaria Prevention Trial
10. Financial incentives may hold key to cutting child malaria deaths
11. Government of Madagascar and Coalition of Global Partners Launch Measles and Malaria Prevention Campaign
Post Your Comments:
Related Image:
Malaria Vaccine Shows Promise in Small Trial
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: